Recent breakthroughs in the diagnosis and treatment of Alzheimer’s disease have been made possible because of the many volunteers who take part in clinical research studies. Our clinic is taking part in the GN30009 study for people in various stages of Alzheimer’s disease. This study is evaluating an investigational imaging agent for positron emission tomography (PET). It may help doctors to diagnose Alzheimer’s disease, and to follow how the disease progresses, by allowing them to see changes inside the brains of patients.
Qualified participants for this study must:
• be 50-85 years old
• have a diagnosis of prodromal, mild, or moderate Alzheimer’s disease
• have a study partner or close friend who can attend study visits with the participant
• be willing to travel to New Haven, Connecticut approximately every 6 months, for a total of 4 scheduled visits to New Haven
Your medical history and other criteria will be reviewed at the first study visit to see if you can be in the study.
If you qualify, you may be in the study for up to 20 months. There will be 6 visits to our local study clinic and 4 scheduled visits to a special medical imaging facility in New Haven, Connecticut. Each of these visits to New Haven will require a 2-3 day trip.
Travel expenses to New Haven and hotel accommodations for you and your study partner will be paid for by the study. All study-related procedures will be provided at no cost, and you may also be compensated for your time.
We encourage you to discuss study participation with your regular physician and family.
If you’d like to enroll to this clinical trial, complete the form below and we’ll get back to you:
For more information, please call Estela Soniel at (973) 398 2900. You can also send an email to email@example.com.
ClinicalTrials.gov Identifier: NCT02640092
Reference Study ID Number: GN30009